Krsnaa Diagnostics Yönetim
Yönetim kriter kontrolleri 2/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Mitesh Dave
İcra Kurulu Başkanı
n/a
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | less than a year |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 2.6yrs |
| Yönetim Kurulu ortalama görev süresi | 3.6yrs |
Son yönetim güncellemeleri
Recent updates
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Sep 06
Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Aug 23Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 10Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Aug 09Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors
Jul 05Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return
Jun 16We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings
May 26Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?
Mar 14Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 16Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 31Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 17Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)
Jun 03Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 17Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)
Feb 16Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think
Nov 17CEO
Mitesh Dave
less than a year
Görev süresi
Mr. Mitesh Dave is Group Chief Executive Officer of Krsnaa Diagnostics Limited from June 1, 2024. Mr. Mitesh Dave has two decades of diverse industry experience. His track record spans FMCG, OTC, Pharmaceu...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 3.6yrs | ₹25.90m | 24.87% ₹ 7.4b | |
| Chief Financial Officer | 3.8yrs | ₹3.00m | Veri yok | |
| Company Secretary & Compliance Officer | 1.3yrs | ₹1.33m | Veri yok | |
| Joint MD | 5.8yrs | ₹54.40m | 0.68% ₹ 203.6m | |
| Group Chief Executive Officer | less than a year | Veri yok | Veri yok | |
| National Sales Head | no data | Veri yok | Veri yok | |
| Vice President | no data | ₹2.99m | Veri yok |
2.6yrs
Ortalama Görev Süresi
41yo
Ortalama Yaş
Deneyimli Yönetim: KRSNAA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.6 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 3.6yrs | ₹25.90m | 24.87% ₹ 7.4b | |
| Joint MD | 5.8yrs | ₹54.40m | 0.68% ₹ 203.6m | |
| Independent Director | 2.5yrs | ₹1.15m | Veri yok | |
| Non Executive Director | no data | Veri yok | Veri yok | |
| Independent Director | no data | ₹1.05m | Veri yok | |
| Independent Director | no data | ₹1.00m | Veri yok | |
| Independent Director | no data | ₹1.00m | Veri yok |
3.6yrs
Ortalama Görev Süresi
68yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: KRSNAA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.6 yıldır).